You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The researchers found the method has high sensitivity and specificity and are now offering it clinically at UW.
As part of the CORRECT trial, researchers compared analyses of liquid and tissue biopsies, finding support for using circulating DNA to follow tumor progression.
A proof-of-principle study suggests blood and saliva may contain markers for finding and following head and neck squamous cell carcinomas.
The group found that a combination of algorithms performs better than any one single algorithm.
Dutch and US researchers have conducted a genome-wide analysis of de novo mutations in humans and developed a genome-wide mutation rate map.
By Ben Butkus
Life Technologies this week announced the expansion of its TaqMan Mutation Detection Assays based on competitive allele-specific TaqMan, or Cast, PCR technology.
Transgenomic and the University of Texas MD Anderson Cancer Center have initiated a collaboration to evaluate Transgenomic's mutation detection technology in cancer patients, Transgenomic said this week.
This article has been updated from a previous version to correct a numerical error.
By Ben Butkus
A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.
According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.
In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.
The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.